Aerobic capacity in adult dermatomyositis/polymyositis patients and healthy controls

被引:65
作者
Wiesinger, GF
Quittan, M
Nuhr, M
Volc-Platzer, B
Ebenbichler, G
Zehetgruber, M
Graninger, W
机构
[1] Univ Vienna, Dept Phys Med & Rehabil, Vienna, Austria
[2] Univ Vienna, Dept Internal Med 3, Div Rheumatol, Vienna, Austria
[3] Univ Vienna, Dept Dermatol, Div Immunol Allergy & Infect Dis, Vienna, Austria
[4] Univ Vienna, Dept Internal Med 2, Div Cardiol, Vienna, Austria
来源
ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION | 2000年 / 81卷 / 01期
关键词
exercise; aerobic; dermatomyositis; polymyositis; rehabilitation;
D O I
10.1016/S0003-9993(00)90212-0
中图分类号
R49 [康复医学];
学科分类号
100215 ;
摘要
Objective: Assessment of myositis patients has relied on symptoms, strength testing, and serum muscle enzyme activity. Recently, functional assessments and evaluation of strength by dynamometry and of disease activity by magnetic resonance imaging have also been added. Aerobic testing in selected patients has been considered useful. Design: Case-control study. Setting: University Hospital, Vienna, Austria. Patients: Twenty-two subjects (8 outpatients with chronic dermatomyositis and 3 outpatients with chronic polymyositis, and 11 healthy controls) participated, allowing the identification of 11 case-control pairs matched by age (+/-3 years) and gender (mean age, 48 +/- 14yrs; ratio of women to men, 18/4). Main Outcome Measures: Target parameters were peak oxygen uptake (peak (V) over dot O-2) to estimate aerobic exercise capacity and peak isometric torque for muscle strength. Creatine phosphokinase (CPK) was measured to assess elevation of muscle enzymes. Results: The mean peak (V) over dot O-2 in patients with dermatomyositis/ polymyositis was 15.3mL/min/kg(SD = 5.8) and in the healthy controls 28.7 mL/min/kg (SD = 7.8). Cardiorespiratory capacity expressed as peak (V) over dot O-2 was thus significantly reduced at 53% (p =.0001) of the control value. Muscle strength expressed as peak isometric torque was significantly lower (p =.01) in patients (mean 148 +/- 73 Nm) when compared to the control group (mean 261 +/- 99Nm). In myositis patients peak (V) over dot O-2 and peak isometric torque correlate well with each other (r =.7631; p =.0001), but not at all with serum CPK levels (r =.056; p=.869). Conclusion: Peak (V) over dot O-2 is significantly diminished in patients with dermatomyositis/polymyositis, compared with age- and sex-matched controls. Serum CPK did not significantly correlate with (V) over dot O-2 Aerobic exercise testing may be a useful assessment parameter in selected patients with dermatomyositis/ polymyositis.
引用
收藏
页码:1 / 5
页数:5
相关论文
共 46 条
[21]  
HOWLEY ET, 1995, MED SCI SPORT EXER, V27, P1292
[22]  
Josefson A, 1996, J RHEUMATOL, V23, P1380
[23]   CREATINE-KINASE ACTIVITY INHIBITOR IN SERA FROM PATIENTS WITH MUSCLE DISEASE [J].
KAGEN, LJ ;
ARAM, S .
ARTHRITIS AND RHEUMATISM, 1987, 30 (02) :213-217
[24]  
Klepper S E, 1992, Arthritis Care Res, V5, P93, DOI 10.1002/art.1790050208
[25]  
KROLL M, 1986, J RHEUMATOL, V13, P349
[26]  
KROLL MA, 1988, J RHEUMATOL, V15, P1782
[27]   PULMONARY-DISEASE IN POLYMYOSITIS DERMATOMYOSITIS - A CLINICOPATHOLOGICAL ANALYSIS OF 65 AUTOPSY CASES [J].
LAKHANPAL, S ;
LIE, JT ;
CONN, DL ;
MARTIN, WJ .
ANNALS OF THE RHEUMATIC DISEASES, 1987, 46 (01) :23-29
[28]   CLINICAL, BIOCHEMICAL AND HISTOLOGICAL RESPONSES TO TREATMENT IN POLYMYOSITIS - A PROSPECTIVE-STUDY [J].
LANE, RJM ;
EMSLIESMITH, A ;
MOSQUERA, IE ;
HUDGSON, P .
JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 1989, 82 (06) :333-338
[29]  
MADER R, 1993, J RHEUMATOL, V20, P1105
[30]   ADVERSE-EFFECTS OF DRUGS ON MUSCLE [J].
MASTAGLIA, FL .
DRUGS, 1982, 24 (04) :304-321